1The SOLVD investigators. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduce left ventricular ejection fractions [J], N Engl Med J, 1992; 327:685-91.
4Homig B, Saxon LA, Scheinman MM, et al, Different effects of quinapril and enalaprillat on endothelial function of conduit arteries in patients with chronic heart failure[J], Circulation, 1998; 25 : 2842-8.
5Anderson TJ,Cazeau S,Leclercq C, et al. Comparative study of ACE-inhibition, angiotensin Ⅱ antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease [ J ]. J Am Coil Cardiol,2000 ; 35 ( 1 ) : 60-6.
6Dzau VJ,Nattel S,Singh BN,et al . The relevance of tissue angiotensin -converting enzyme:manifestations in mechanistic and endpoint data [ J].Am J Cardiol, 2001 ;88(9A) :1-20.
二级参考文献1
1Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
6Vijayaraghavan K, Deedwania P. Renin-angiotensin-ahloslemne bloekade for cardiovaseular disease prevention [J]. Cardiol Clin ,2011 ;29 ( 1 ) : 137-56.
7Konstatn MA,Kramer I)G, Palel AR,et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment [J]. JACC Cariovase Imaging,2011 ;4(1) :98-108.
8Simone G, Kizer JR, Chinali M, et al. Normalization for body size and pop- ulation-attribulable risk of left ventricular hypertrophy: the strong heart stu(iy [ J ]. Am J Hypertens ,2005 ; 18 ( 2 ) : 191-6.
9Kaur K,Dhingra S,Slezak J,et al. Biology of TNF alpha and IL-10,and their imbalance in heart failure [ J ]. Heart Fail Rev,2009 ; 14 ( 2 ) : 113 -23.
